60 day FRN

46827

Federal Register / Vol. 79, No. 154 / Monday, August 11, 2014 / Notices
LeRoy Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–18845 Filed 8–8–14; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–14–14ARJ]

Proposed Data Collections Submitted
for Public Comment and
Recommendations
The Centers for Disease Control and
Prevention (CDC), as part of its
continuing effort to reduce public
burden, invites the general public and
other Federal agencies to take this
opportunity to comment on proposed
and/or continuing information
collections, as required by the
Paperwork Reduction Act of 1995. To
request more information on the below
proposed project or to obtain a copy of
the information collection plan and
instruments, call 404–639–7570 or send
comments to Leroy Richardson, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an email to [email protected].
Comments submitted in response to
this notice will be summarized and/or
included in the request for Office of
Management and Budget (OMB)
approval. Comments are invited on: (a)
Whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the

quality, utility, and clarity of the
information to be collected; (d) ways to
minimize the burden of the collection of
information on respondents, including
through the use of automated collection
techniques or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. Written comments should
be received within 60 days of this
notice.

guidelines for its use. Because
approximately 50,000 new HIV
infections continue to occur each year,
with rates of HIV infection increasing
most rapidly for young MSM and
because severe disparities in HIV
infection continue among AfricanAmerican men and women,
incorporation of PrEP into HIV
prevention is important. However, as a
prevention tool in very early stages of
introduction and use, there is much we
need to learn about how to implement
PrEP in a real-world setting.
CDC is requesting OMB approval to
collect data over a 3-year period that
will be used to conduct research among
clinicians about their knowledge,
attitudes, and practices related to a new
intervention (PrEP) over the period of its
initial introduction in their clinics. The
knowledge gained will be used to refine
measurement instruments and methods
(for example, identify modifications to
questions in the current surveys that are
unclear to participants), develop
training and educational resources and
tools for use by CDC/DHAP (Division of
HIV/AIDS Prevention)-funded partners,
and other organizations supporting
delivery of PrEP in clinical settings.
The project will be conducted in
clinics in each of four cities (Houston,
Newark, Chicago, and Philadelphia)
where PrEP has recently become
available through a local community
health center.
Once per year for 3 years, CDC will
conduct an online survey of clinicians
at participating clinics to collect data on
the demographics of the respondents
and their knowledge, attitudes,
practices, and organizational factors
related to PrEP and its delivery in their
clinics. Surveys will be administered
through an online survey Web site.
There are no costs to respondents
other than their time.

Proposed Project
Clinic Context Matters Study–New–
National Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention
(NCHHSTP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The daily use of specific antiretroviral
medications by persons without HIV
infection, but at high risk of sexual or
injection exposure to HIV, has been
shown to be a safe and effective HIV
prevention method. The Food and Drug
Administration approved the use of
Truvada® for preexposure prophylaxis
(PrEP) in July 2012 and CDC has issued
Public Health Service clinical practice

mstockstill on DSK4VPTVN1PROD with NOTICES

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent

Average hours
per response

Total
response burden hours)

175

1

30/60

88

........................

........................

........................

88

Number of
respondents

Type of respondent

Form name

Clinician .............................................

Clinician Consent and Interview ......

Total ...........................................

...........................................................

Leroy Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–18940 Filed 8–8–14; 8:45 am]
BILLING CODE 4163–18–P

VerDate Mar<15>2010

17:35 Aug 08, 2014

Jkt 232001

PO 00000

Frm 00059

Fmt 4703

Sfmt 9990

E:\FR\FM\11AUN1.SGM

11AUN1